HEART DEFECTS, CONGENITAL
Clinical trials for HEART DEFECTS, CONGENITAL explained in plain language.
Never miss a new study
Get alerted when new HEART DEFECTS, CONGENITAL trials appear
Sign up with your email to follow new studies for HEART DEFECTS, CONGENITAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart drug study halted early: what we know
Disease control TerminatedThis study tested an experimental drug called CRD-4730 in people with a rare inherited heart rhythm disorder (CPVT) that can cause dangerous fast heartbeats. Seven adults received two different doses of the drug and a placebo to check safety and how the body processes it. The stu…
Matched conditions: HEART DEFECTS, CONGENITAL
Phase: PHASE2 • Sponsor: Cardurion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Wireless heart monitor for infants tested, but study ends early
Knowledge-focused TerminatedThis study aimed to see if a wireless sensor could collect health information from babies with heart defects at home, replacing wired devices. Only 2 infants were enrolled before the study was stopped. The goal was to understand if the wireless device was easy to use and worked w…
Matched conditions: HEART DEFECTS, CONGENITAL
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC